New RAS-mutant pancreatic adenocarcinoma with combined BRAF and MEK inhibition for metastatic melanoma.
- Resource Type
- Academic Journal
- Source
Journal of Clinical Oncology (J CLIN ONCOL), 4/10/2015; 33(11): e52-6. (1p)- Subject
- Language
- English
- ISSN
- 0732-183X